Education
About Us
Working with TipRanks
Follow Us
Rici Healthcare Holdings Ltd. (HK:1526)
:1526
1526 Stock Chart & Stats
HK$0.99
-HK$0.01(-0.85%)
At close: 4:00 PM EST
HK$0.99
-HK$0.01(-0.85%)
Day’s Range― - ―
52-Week RangeHK$0.71 - HK$1.26
Previous CloseN/A
Volume109.00K
Average Volume (3M)125.43K
Market Cap
HK$1.53B
Enterprise ValueHK$2.57B
Total Cash (Recent Filing)HK$1.03B
Total Debt (Recent Filing)HK$2.25B
Price to Earnings (P/E)5.3
Beta0.23
Next Earnings
Mar 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.37%
Share Statistics
EPS (TTM)0.04
Shares Outstanding1,590,324,000
10 Day Avg. Volume143,000
30 Day Avg. Volume125,433
Financial Highlights & Ratios
PEG Ratio-0.36
Price to Book (P/B)1.39
Price to Sales (P/S)0.64
P/FCF Ratio3.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Profit MarginsThe company reports robust gross (39.9%) and net (10.2%) margins, indicating durable operational efficiency in manufacturing and product mix. High margins provide recurring cash buffer to support R&D, product development and withstand pricing pressure in med‑tech markets over the medium term.
High Return On EquityA 22.1% ROE reflects effective use of shareholders' capital and suggests the business generates returns above cost of equity. Sustained ROE supports internal funding for growth and signals competitive positioning if maintained, attracting capital and enabling strategic reinvestment.
Diversified Healthcare Revenue StreamsMultiple revenue streams—proprietary device sales, R&D partnerships, licensing and potential government contracts—reduce single‑market dependency. This diversification aligns with structural healthcare demand and can stabilize cash flows and support incremental margin expansion over 2–6 months.
Bears Say
High LeverageA 1.71 debt/equity ratio implies meaningful financial leverage that increases interest burden and earnings volatility. High leverage limits flexibility for capex or acquisitions, raises refinancing risk, and amplifies downside if revenue weakens or rates rise, pressuring long‑term stability.
Zero Free Cash FlowZero free cash flow constrains the company’s ability to self‑fund growth, service debt, or increase shareholder distributions. With limited internal cash generation, the firm may need external financing for R&D or capex, increasing cost of capital and reducing margin for strategic initiatives.
Declining Revenue TrendA persistent revenue decline signals potential market share loss or demand softness. Even with healthy margins, shrinking top line constrains long‑term margin expansion and cash generation. Reversing this requires successful new product launches or market expansion amid competitive pressures.
Rici Healthcare Holdings Ltd. News
1526 FAQ
What was Rici Healthcare Holdings Ltd.’s price range in the past 12 months?
Rici Healthcare Holdings Ltd. lowest stock price was HK$0.71 and its highest was HK$1.26 in the past 12 months.
What is Rici Healthcare Holdings Ltd.’s market cap?
Rici Healthcare Holdings Ltd.’s market cap is HK$1.53B.
When is Rici Healthcare Holdings Ltd.’s upcoming earnings report date?
Rici Healthcare Holdings Ltd.’s upcoming earnings report date is Mar 26, 2026 which is in 31 days.
How were Rici Healthcare Holdings Ltd.’s earnings last quarter?
Rici Healthcare Holdings Ltd. released its earnings results on Aug 28, 2025. The company reported HK$0.038 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.038.
Is Rici Healthcare Holdings Ltd. overvalued?
According to Wall Street analysts Rici Healthcare Holdings Ltd.’s price is currently Overvalued.
Does Rici Healthcare Holdings Ltd. pay dividends?
Rici Healthcare Holdings Ltd. pays a Notavailable dividend of HK$0.045 which represents an annual dividend yield of 4.37%. See more information on Rici Healthcare Holdings Ltd. dividends here
What is Rici Healthcare Holdings Ltd.’s EPS estimate?
Rici Healthcare Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rici Healthcare Holdings Ltd. have?
Rici Healthcare Holdings Ltd. has 1,590,324,000 shares outstanding.
What happened to Rici Healthcare Holdings Ltd.’s price movement after its last earnings report?
Rici Healthcare Holdings Ltd. reported an EPS of HK$0.038 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Rici Healthcare Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:1526
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Rici Healthcare Holdings Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-22.31%
12-Months-Change
Fundamentals
Return on Equity
20.47%
Trailing 12-Months
Asset Growth
5.86%
Trailing 12-Months
Company Description
Rici Healthcare Holdings Ltd.
Rici Healthcare Holdings Ltd. (1526) is a healthcare investment company based in Hong Kong, primarily focusing on the development, manufacturing, and distribution of medical devices and healthcare products. The company operates within the healthcare sector, with a portfolio that includes innovative medical technologies, diagnostic tools, and healthcare solutions aimed at improving patient outcomes and enhancing the efficiency of healthcare delivery.
Technical Analysis
Honliv Healthcare Management Group Co Ltd
―
Human Health Holdings Ltd.
―
Guangdong Kanghua Healthcare Co., Ltd. Class H
―
Hospital Corporation of China Ltd
―
Town Health International Medical Group Ltd.
―